Skip to main content
. 2024 May 16;5(8):100684. doi: 10.1016/j.jtocrr.2024.100684

Table 1.

Demographic and Clinical Characteristics of Patients in the Pathways of Care

Patient-Level Variable Lung Cancer Screening
Lung Nodule Program
Non–Program Based
p-Value
n = 111 n = 357 n = 1120
Age, n (%) 0.0048
 <49 - 6 (2) 33 (3)
 50–64 29 (26) 84 (24) 296 (26)
 65–80 82 (74) 234 (66) 722 (64)
 >80 - 33 (9) 69 (6)
Mean (SD) 68.4 (5.7) 69.7 (9.1) 68.4 (9) 0.0205
 Median (Q1, Q3) 69 (64, 73) 70 (64, 76) 69 (63, 75)
Race, n (%) 0.0905
 White 93 (84) 274 (77) 863 (77)
 Black 18 (16) 71 (20) 243 (22)
 Other - 10 (3) 12 (1)
 Not reported - 2 (1) 2 (0)
Sex, n (%) 0.2347
 Male 51 (46) 157 (44) 549 (49)
 Female 60 (54) 200 (56) 571 (51)
Insurance, n (%) 0.7819
 Medicare 52 (47) 171 (48) 541 (48)
 Medicaid 13 (12) 45 (13) 168 (15)
 Commercial 45 (41) 135 (38) 397 (35)
 Self-Insured/None 1 (1) 6 (2) 14 (1)
Smoking Status <0.0001
 Active 67 (60) 134 (38) 453 (40)
 Former 44 (40) 158 (44) 516 (46)
 Never - 65 (18) 149 (13)
 Not Reported 2 (0)
Charlson Comorbidity Score, n (%) 0.0143
 0 19 (17) 102 (29) 301 (27)
 1 73 (66) 174 (49) 548 (49)
 ≥2 19 (17) 81 (23) 271 (24)
Co-morbidities 0.292
 Mean (SD) 2.3 (1) 2.2 (1.2) 2.2 (1.2)
 Median (Q1, Q3) 2 (2, 3) 2 (1, 3) 2 (1, 3)

SD, standard deviation; Q, quartile.